Charlson syndrome index predicted survival in pancreatic cancer patients received immunotherapy by Nan Zhang, Nan Zhang, Shiyun Chen, Yue Shi, Zhikuan Wang, Ru Jia, Guanghai Dai, Guanghai Dai

Subjects: Get full text

Current status of cytokine-induced killer cells and combination regimens in breast cancer by Yuancong Jiang, Jie Qiu, Nanwei Ye, Yingchun Xu

Subjects: Get full text

The effects of hyperbaric treatment on perianal fistula activity in patients with Crohn’s disease by Grażyna Piotrowicz, Jacek Kot, Andrzej Babicki, Piotr Banaszkiewicz, Adam Piotrowicz, Magdalena Rzeszutek, Agata Rudnik, Piotr Zientara, Joanna Adamska-Mieruszewska, Grażyna Rydzewska

Subjects: Get full text

Resveratrol-loaded metal-organic framework for mitochondria-targeted amplified CO gas therapy by Fengqin Wang, Yinfang Jiang, Yang Wang

Subjects: Get full text

Dynamical properties and tumor clearance conditions for a nine-dimensional model of bladder cancer immunotherapy by K. E. Starkov, Svetlana Bunimovich-Mendrazitsky

Subjects: Get full text

Synergistic effect of defocus incorporated multiple segment glasses and repeated low level red light therapy against myopia progression by Yan Yang, Shenghong Liu, Wenwen Gao, Lei Wang, Na Liu, Shiying Zhang, Lianjing Yang, Lingyun Cheng

Subjects: Get full text

Systematic Review and Meta-Analysis on Human African Trypanocide Resistance by Keneth Iceland, Kasozi, Ewan Thomas, MacLeod, Susan Christina, Welburn

Subjects: “…Nifurtimox/eflornithine combination therapy;…”
Get full text

Bimatoprost Intracameral Implant (Durysta®): A New Era in Glaucoma Management Through Sustained-Release Innovation by Vagiakis I, Papadopoulou EP, Amaxilati E, Tsiropoulos GN, Konstas AG, Panos GD

Subjects: Get full text

Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phas... by Jorge E. Cortes, Gail J. Roboz, Maria R. Baer, Brian A. Jonas, Gary J. Schiller, Karen Yee, P. Brent Ferrell, Jay Yang, Eunice S. Wang, William G. Blum, Alice Mims, Hua Tian, Aaron Sheppard, Stéphane de Botton, Pau Montesinos, Antonio Curti, Justin M. Watts, the Olutasidenib Combination Therapy Study Group

Get full text

Generalized Propensity Score Matching with Multilevel Treatment Options by Onur Baser

“…Under non-FFS group, reliever only therapy totaled $1,266; controller only therapy was $1,959, and combination therapy totaled $1,933. Although the cost difference between reliever only and combination therapy was significant, there was no evidence that combination therapy cost more than controller only therapy. …”
Get full text

Intramuscular Injection of Adenoassociated Virus Encoding Human Neurotrophic Factor 3 and Exercise Intervention Contribute to Reduce Spasms after Spinal Cord Injury by Yu-Xin Chang, Yan Zhao, Su Pan, Zhi-Ping Qi, Wei-Jian Kong, Yi-Ran Pan, Hong-Ru Li, Xiao-Yu Yang

“…Our goal is to develop a combination therapy based on individualized medicine to reduce spasticity after spinal cord injury. …”
Get full text

DC-Based Immunotherapy Combined with Low-Dose Methotrexate Effective in the Treatment of Advanced CIA in Mice by Jun-Eui Park, Jinah Jang, Ji-Hye Choi, Mi-sun Kang, Yun-Ju Woo, Young-Rim Seong, Chan-Bum Choi, Hye-Soon Lee, Sang-Cheol Bae, Yong-Soo Bae

“…In the present study, we examined the efficacy of combination therapy with smDCs and methotrexate (MTX) in advanced CIA with a score of 2-3. …”
Get full text

A Case of Primary Refractory Immune Thrombocytopenia: Challenges in Choice of Therapies by Hanyin Wang, Hande Tuncer

“…The value of combination therapy for refractory ITP is not well defined. …”
Get full text

Why and How to Treat Chronic Hepatitis C by Stephanos J Hadziyannis

“…Combination therapy has also been proven to be effective in approximately 50% of relapsed responders to IFN-α monotherapy. …”
Get full text

Neuroleptic Malignant Syndrome Caused by a Combination of Carbamazepine and Amitriptyline by A. Bruce Janati, Naif ALGhasab, Aboubaker Osman

“…We conclude that combination therapy with carbamazepine and amitriptyline should be avoided in patients who are predisposed to NMS. …”
Get full text

The synergism of occlusal splints along with therapeutic exercise on individuals with temporomandibular joint disorders – A pilot study by Tanuj Bachani, Fathima Banu Raza, Anand Kumar Vaidyanathan

“…An isotonic muscle activity pattern was also observed, confirming the effect of combination therapy.…”
Get full text

Improving ROP management: insights from a comparative analysis of screening and treatment modalities in a tertiary hospital, Pakistan by Muhammad Moin, Aisha Azam, Lubna Siddiq Mian, Ashal Pal, Rutaab Kareem, Noor Us Sehar

“…Zone 1 infants were more likely to receive anti-VEGF or combination therapy, whereas Zone 2 infants predominantly received laser therapy (p < 0.000). …”
Get full text

A Case of Persistent Bacillus cereus Bacteremia Responding to a Combination of Vancomycin and Gentamicin by Hiroshi Sasano, Toshihiro Yoshizawa, Mai Suzuki, Yukiko Fukui, Ryutarou Arakawa, Naoto Tamura, Toshio Naito

“…Persistent B. cereus bacteremia responded to combination therapy with VCM and GM. This combination therapy may increase the risk of developing renal dysfunction, but the risk can be mitigated by appropriate therapeutic drug monitoring (TDM) and dose adjustments to achieve successful treatment.…”
Get full text

Papaverine Enhances the Oncolytic Effects of Newcastle Disease Virus on Breast Cancer In Vitro and In Vivo by Sura Akram, Ahmed Majeed Al-Shammari, Hayder B. Sahib, Majid Sakhi Jabir

“…In vitro, results showed that the combination therapy induces synergistic cytotoxicity and apoptosis against cancer cells with a negligible cytotoxic effect on normal cells. …”
Get full text

Fulminant Disseminated Intravascular Coagulation as Initial Presentation of BRAF-Mutated Melanoma by Jeremy Chuang, An Uche, Rohan Gupta, Kim Margolin, Phyllis Kim

“…In this case report, we discuss a 33-year-old woman with BRAF V600E-mutated metastatic melanoma who presented in fulminant DIC with concurrent hemorrhagic and thrombotic manifestations and discuss the patient’s brief response to combination therapy. In our discussion, we highlight the current understanding of DIC and also identify opportunities for future research to elucidate the genetic aberrations in melanoma that may result in treatment resistance to combination therapy.…”
Get full text